Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia.
暂无分享,去创建一个
S. Biswal | L. Kobzik | R. Thimmulappa | G. DeLoid | John G. Gibbons | A. Bedugnis | Muzo Wu | J. Gibbons
[1] Jian Jin,et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation , 2016, Science.
[2] J. Pedraza-Chaverri,et al. Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways , 2016, Free radical research.
[3] G. Sudhandiran,et al. Celastrol enhances Nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis. , 2016, Chemico-biological interactions.
[4] W. Kuebler,et al. Influenza-Induced Priming and Leak of Human Lung Microvascular Endothelium upon Exposure to Staphylococcus aureus. , 2015, American journal of respiratory cell and molecular biology.
[5] W. Cao,et al. Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis , 2015, Arthritis Research & Therapy.
[6] Yingxian Sun,et al. Triptolide Attenuates Myocardial Ischemia/Reperfusion Injuries in Rats by Inducing the Activation of Nrf2/HO-1 Defense Pathway , 2015, Cardiovascular Toxicology.
[7] Na Liu,et al. Epigallocatechin‐3‐Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF‐κB and Nrf2/HO‐1 Signalling Pathway Regulation , 2015, Basic & clinical pharmacology & toxicology.
[8] Kevin J. McHugh,et al. Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice. , 2015, American journal of physiology. Lung cellular and molecular physiology.
[9] T. Stossel,et al. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function. , 2015, American journal of physiology. Lung cellular and molecular physiology.
[10] K. M. Robinson,et al. The immunology of influenza virus-associated bacterial pneumonia. , 2015, Current opinion in immunology.
[11] R. Webby,et al. Nonstructural protein 1 (NS1)-mediated inhibition of c-Abl results in acute lung injury and priming for bacterial co-infections: insights into 1918 H1N1 pandemic? , 2015, The Journal of infectious diseases.
[12] J. Alcorn,et al. The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia , 2015, Respiratory Research.
[13] G. Gao,et al. Influenza viral neuraminidase primes bacterial coinfection through TGF-β–mediated expression of host cell receptors , 2014, Proceedings of the National Academy of Sciences.
[14] Yong Zhao,et al. Interferon-γ Inhibits Nonopsonized Phagocytosis of Macrophages via an mTORC1-c/EBPβ Pathway , 2014, Journal of Innate Immunity.
[15] S. Siegel,et al. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. , 2014, Cell host & microbe.
[16] Nnamdi E. Ihuegbu,et al. Innate host defense requires TFEB-mediated transcription of cytoprotective and antimicrobial genes. , 2014, Immunity.
[17] George R Tiller,et al. Of worms and men: HLH-30 and TFEB regulate tolerance to infection. , 2014, Immunity.
[18] V. Boggaram,et al. Protecting against post-influenza bacterial pneumonia by increasing phagocyte recruitment and ROS production. , 2014, The Journal of infectious diseases.
[19] Jie Han,et al. (−)-Epigallocatechin Gallate Protects Against Cerebral Ischemia-Induced Oxidative Stress via Nrf2/ARE Signaling , 2014, Neurochemical Research.
[20] Alex K. Heer,et al. Alveolar Macrophages Are Essential for Protection from Respiratory Failure and Associated Morbidity following Influenza Virus Infection , 2014, PLoS pathogens.
[21] D. Metzger,et al. Influenza Infection Suppresses NADPH Oxidase–Dependent Phagocytic Bacterial Clearance and Enhances Susceptibility to Secondary Methicillin-Resistant Staphylococcus aureus Infection , 2014, The Journal of Immunology.
[22] Kevin J. McHugh,et al. Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production. , 2014, The Journal of infectious diseases.
[23] J. McCullers. The co-pathogenesis of influenza viruses with bacteria in the lung , 2014, Nature Reviews Microbiology.
[24] Kevin J. McHugh,et al. Influenza A Exacerbates Staphylococcus aureus Pneumonia by Attenuating IL-1β Production in Mice , 2013, The Journal of Immunology.
[25] C. Hogaboam,et al. Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses. , 2013, The American journal of pathology.
[26] P. Thomas,et al. Depletion of Alveolar Macrophages during Influenza Infection Facilitates Bacterial Superinfections , 2013, The Journal of Immunology.
[27] Ruslan Medzhitov,et al. Role of Tissue Protection in Lethal Respiratory Viral-Bacterial Coinfection , 2013, Science.
[28] J. Sirard,et al. Interleukin-22 Reduces Lung Inflammation during Influenza A Virus Infection and Protects against Secondary Bacterial Infection , 2013, Journal of Virology.
[29] Qian Wang,et al. GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data , 2012, Bioinform..
[30] M. Picklo,et al. The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism. , 2012, The Journal of nutritional biochemistry.
[31] T. Walther,et al. The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis , 2012, Science Signaling.
[32] E. Nagata,et al. Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death , 2012, Proceedings of the National Academy of Sciences.
[33] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[34] A. Ballabio,et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB , 2012, The EMBO journal.
[35] Yoon-Jin Lee,et al. Reactive oxygen species and PI3K/Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[36] Chang Deng,et al. Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K/Akt-dependent manner. , 2011, Molecular medicine reports.
[37] A. Ballabio,et al. Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance , 2011, Developmental cell.
[38] P. Puthavathana,et al. Decreased expression of surfactant protein D mRNA in human lungs in fatal cases of H5N1 avian influenza , 2011, Journal of medical virology.
[39] Andrea Ballabio,et al. TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.
[40] S. Lal,et al. Influenza virus and cell signaling pathways , 2011, Medical science monitor : international medical journal of experimental and clinical research.
[41] L. Kobzik,et al. MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome. , 2011, American journal of respiratory cell and molecular biology.
[42] L. Yarmus,et al. Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model , 2011, Science Translational Medicine.
[43] J. Taubenberger,et al. The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding. , 2011, Virology.
[44] J. Alcorn,et al. Influenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in Mice , 2011, The Journal of Immunology.
[45] N. Hay,et al. FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. , 2010, Developmental cell.
[46] L. Hall-Stoodley,et al. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. , 2010, American journal of respiratory cell and molecular biology.
[47] David Parham,et al. A mouse model of lethal synergism between influenza virus and Haemophilus influenzae. , 2010, The American journal of pathology.
[48] R. Strieter,et al. Dysregulated Macrophage-Inflammatory Protein-2 Expression Drives Illness in Bacterial Superinfection of Influenza , 2010, The Journal of Immunology.
[49] Shi-Yong Sun. Enhancing perifosine's anticancer efficacy by preventing autophagy , 2010, Autophagy.
[50] L. de Leval,et al. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. , 2009, The Journal of clinical investigation.
[51] A. Ballabio,et al. A Gene Network Regulating Lysosomal Biogenesis and Function , 2009, Science.
[52] A. Imrich,et al. Heterogeneity in Macrophage Phagocytosis of Staphylococcus aureus Strains: High-Throughput Scanning Cytometry-Based Analysis , 2009, PloS one.
[53] A. Shahangian,et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. , 2009, The Journal of clinical investigation.
[54] A. Holian,et al. Critical role of MARCO in crystalline silica-induced pulmonary inflammation. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[55] Matthias Gunzer,et al. Increased Susceptibility for Superinfection with Streptococcus pneumoniae during Influenza Virus Infection Is Not Caused by TLR7-Mediated Lymphopenia , 2009, PloS one.
[56] S. Gordon,et al. Conserved domains of the class A scavenger receptors: evolution and function , 2009, Immunological reviews.
[57] M. Bergeron,et al. Infection with Human Metapneumovirus Predisposes Mice to Severe Pneumococcal Pneumonia , 2008, Journal of Virology.
[58] A. Imrich,et al. Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry , 2008, Respiratory research.
[59] Robert George,et al. Bacterial Pneumonia and Pandemic Influenza Planning , 2008, Emerging infectious diseases.
[60] M. Pulse,et al. Stress-induced differences in primary and secondary resistance against bacterial sepsis corresponds with diverse corticotropin releasing hormone receptor expression by pulmonary CD11c+ MHC II+ and CD11c− MHC II+ APCs , 2008, Brain, Behavior, and Immunity.
[61] D. Metzger,et al. Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection , 2008, Nature Medicine.
[62] Richard B. Brown,et al. Complications of Viral Influenza , 2008, The American Journal of Medicine.
[63] B. Lambrecht,et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection , 2008, The Journal of experimental medicine.
[64] K. Nocka,et al. IN VITRO MODELING OF HUMAN ALVEOLAR MACROPHAGE SMOKE EXPOSURE: ENHANCED INFLAMMATION AND IMPAIRED FUNCTION , 2008, Experimental lung research.
[65] Kelli L Boyd,et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. , 2007, Cell host & microbe.
[66] S. Kleeberger,et al. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. , 2007, The Journal of clinical investigation.
[67] J. Rehg,et al. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. , 2007, Comparative medicine.
[68] S. Gordon,et al. The interaction of macrophage receptors with bacterial ligands , 2006, Expert Reviews in Molecular Medicine.
[69] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[70] A. Brewer,et al. GATA factors in vertebrate heart development and disease , 2006, Expert Reviews in Molecular Medicine.
[71] S. Reddy,et al. Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells. , 2006, Antioxidants & redox signaling.
[72] T. van der Poll,et al. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. , 2006, The Journal of infectious diseases.
[73] Hengjun Chao,et al. RNA repair for haemophilia A , 2006, Expert Reviews in Molecular Medicine.
[74] F. Kishi,et al. Functional heterogeneity of colony‐stimulating factor‐induced human monocyte‐derived macrophages , 2006, International journal of hematology.
[75] Hiroshi Yasui,et al. Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. , 2005, Blood.
[76] A. Imrich,et al. MARCO Is the Major Binding Receptor for Unopsonized Particles and Bacteria on Human Alveolar Macrophages1 , 2005, The Journal of Immunology.
[77] S. Meydani,et al. The Effect of Vitamin E on Secondary Bacterial Infection after Influenza Infection in Young and Old Mice , 2004, Annals of the New York Academy of Sciences.
[78] J. McCullers. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. , 2004, The Journal of infectious diseases.
[79] K. Tryggvason,et al. The Scavenger Receptor MARCO Is Required for Lung Defense against Pneumococcal Pneumonia and Inhaled Particles , 2004, The Journal of experimental medicine.
[80] T. van der Poll,et al. IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection , 2004, The Journal of Immunology.
[81] C. Sweet,et al. Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release. , 2003, The Journal of general virology.
[82] J. McCullers,et al. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. , 2003, The Journal of infectious diseases.
[83] B. Vargaftig,et al. Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production , 2003, Immunology.
[84] S. Biswal,et al. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. , 2002, Cancer research.
[85] J. Rehg,et al. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. , 2002, The Journal of infectious diseases.
[86] K. Itoh,et al. A Sulforaphane Analogue That Potently Activates the Nrf2-dependent Detoxification Pathway* , 2002, The Journal of Biological Chemistry.
[87] Michael C. Ostrowski,et al. Cloning and characterization of the murine genes for bHLH-ZIP transcription factors TFEC and TFEB reveal a common gene organization for all MiT subfamily members. , 1999, Genomics.
[88] N. Copeland,et al. The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. , 1998, Development.
[89] Philip R. Cohen,et al. PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.
[90] M. Plotkowski,et al. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. , 1986, The American review of respiratory disease.
[92] R. Lutter,et al. UvA-DARE ( Digital Academic Repository ) Bench-to-bedside review : Bacterial pneumonia with influenza-pathogenesis and clinical implications , 2010 .
[93] T. van der Poll,et al. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. , 2006, American journal of physiology. Lung cellular and molecular physiology.